Recombinant Salmonella agona Phosphoserine Aminotransferase (serC) is a bifunctional enzyme critical for serine biosynthesis and pyridoxine production. It catalyzes the transamination of 3-phosphohydroxypyruvate (3-PHP) to 3-phosphoserine (3-PS) using L-glutamate as an amino donor, a key step in the phosphorylated serine biosynthesis pathway . This enzyme has also been implicated in bacterial septation regulation, making it a target for studying Salmonella persistence and pathogenicity .
Serine Biosynthesis: Converts 3-PHP to 3-PS, a precursor for L-serine, critical for protein synthesis and biofilm formation .
Pyridoxine (Vitamin B6) Production: Facilitates vitamin B6 synthesis via the PdxF activity .
SerC exhibits anti-septation activity in Salmonella:
Mechanism: Wild-type SerC inhibits septum formation, while serC mutations lead to spherical cell morphology due to loss of this inhibitory function .
Key Mutations:
Cell Morphology: serC mutants form small, spherical cells, contrasting with filamentous phenotypes in wild-type strains under stress .
Biofilm Regulation: SerC-linked serine biosynthesis impacts biofilm formation, a factor in Salmonella persistence .
Drug Target: Investigating SerC inhibitors could disrupt serine biosynthesis, limiting Salmonella survival .
Biotechnological Tool: Recombinant SerC is used to study PLP-dependent enzyme mechanisms and bacterial metabolism .
Cusabio. (n.d.). Recombinant Salmonella arizonae Phosphoserine aminotransferase (serC). Retrieved from Cusabio.
PLOS Pathogens. (2024). Revealing phylogenomic variations in Salmonella Agona.
PubMed. (2000). Regulation of septation: a novel role for SerC/PdxF in Salmonella.
PMC. (2023). Phosphoserine Aminotransferase Pathogenetic Variants in Serine Deficiency Disorders.
KEGG: sea:SeAg_B0982
Based on homology with characterized SerC proteins, such as the one from Salmonella arizonae, SerC is a full-length protein of approximately 362 amino acids. The protein sequence contains distinct functional domains responsible for its dual activities. Analysis of related SerC proteins reveals a typical aminotransferase fold with substrate binding sites for both phosphoserine and oxoglutarate. While specific structural data for S. agona SerC is limited, the high conservation across Salmonella species suggests structural similarity to the characterized SerC from S. arizonae, which includes critical catalytic residues involved in transamination reactions .
For purification of recombinant SerC from S. agona, researchers should consider the following protocol:
Express the full-length serC gene in a suitable expression system (commonly yeast-based systems have been successful)
Purify using affinity chromatography (His-tag systems are effective)
Perform size exclusion chromatography to ensure homogeneity
Validate purity using SDS-PAGE (>85% purity is recommended)
Store in appropriate buffer conditions with 5-50% glycerol at -20°C/-80°C to maintain stability
When reconstituting lyophilized protein, use deionized sterile water to a concentration of 0.1-1.0 mg/mL. Repeated freeze-thaw cycles should be avoided; instead, prepare working aliquots and store at 4°C for up to one week .
To measure the phosphoserine aminotransferase activity:
Monitor the conversion of 3-phosphohydroxypyruvate to phosphoserine using coupling enzymes and spectrophotometric detection of NADH oxidation
Alternatively, use HPLC to quantify phosphoserine production
To measure the 2-ketoerythroic acid 4-phosphate transaminase (PdxF) activity:
Measure the conversion of 4-phosphohydroxythreonine to 4-phospho-erythronate using similar coupling enzyme systems
To assess the anti-septation activity:
Examine cell morphology changes in complementation assays with SerC-deficient strains
Use phase-contrast microscopy to quantify cell size and septum formation
Evaluate suppression of His(c) filamentation in appropriate genetic backgrounds
For generating SerC mutants in S. agona, researchers should follow these methodological approaches:
Site-directed mutagenesis: Target specific residues known to be involved in either the enzymatic or anti-septation activities
Allelic exchange methods: Replace the native serC with mutant alleles using suicide vectors
CRISPR-Cas9 editing: For precise genomic modifications without antibiotic resistance markers
Transposon mutagenesis: For random mutagenesis screens to identify novel serC interactions
When designing experiments, it's particularly valuable to create separation-of-function mutants that retain biosynthetic activities but lose anti-septation activity, as previous research has identified such variants . This approach helps distinguish between the metabolic and cell division regulatory roles of SerC.
SerC's influence on S. agona virulence appears to be multifaceted. While primarily characterized as a metabolic enzyme, its impact on cell division through anti-septation activity may contribute to bacterial persistence mechanisms. S. agona is known to be a strong biofilm former and can undergo genome rearrangement while entering a viable but non-culturable state while remaining metabolically active . These characteristics may be linked to SerC's regulatory functions beyond metabolism.
Research indicates that S. agona has been increasingly recognized as a prominent cause of gastroenteritis and has the ability to persist in human hosts . The mechanisms of this persistence likely involve complex metabolic adaptations during infection, where SerC may play a role in regulating cell growth and division in response to host environmental challenges.
During Salmonella infection, expression patterns of metabolic genes including serC undergo significant shifts in response to changing environmental conditions. Although specific data for S. agona serC expression during infection is limited in the provided search results, studies of related Salmonella serovars suggest that:
Early infection stage: SerC expression may be upregulated to support rapid bacterial replication
Persistent infection stage: Expression patterns likely shift to support the transition to slower growth and persistence mechanisms
Biofilm formation: SerC regulation may be altered during biofilm establishment, potentially linking to its cell division regulatory functions
Studies on S. agona have shown that during persistent infections (3 weeks to 3 months), genomic rearrangements and increased SNP variation occur , suggesting dynamic adaptations that likely include changes in metabolic enzyme expression patterns, potentially including serC.
The relationship between SerC's biosynthetic and anti-septation activities presents one of the most intriguing aspects of this multifunctional protein. Research has revealed that these functions appear separable, as evidenced by the isolation of serC alleles that have lost their biosynthetic activities but still retain the ability to inhibit septum formation . This suggests that:
The protein domains responsible for each function may be structurally distinct
The anti-septation activity likely involves protein-protein interactions unrelated to the catalytic site
The dual functionality may represent an evolutionary adaptation enabling metabolic regulation of cell division
These findings indicate that SerC may serve as a link between metabolic state and cell division processes, potentially enabling bacteria to coordinate growth with nutrient availability. Advanced structural studies comparing wild-type SerC with separation-of-function mutants would provide valuable insights into the molecular mechanisms underlying this dual functionality.
The regulatory networks controlling serC expression in S. agona remain incompletely characterized, but likely involve:
Metabolic feedback regulation: As SerC functions in serine biosynthesis, its expression is likely regulated by serine levels
Cell cycle-dependent regulation: Given its role in septation, expression may fluctuate throughout the cell cycle
Stress-response pathways: Expression patterns may change during stress conditions, particularly those encountered during host infection
Understanding these regulatory networks requires integrated approaches including:
Transcriptomic analysis under various growth conditions
Chromatin immunoprecipitation to identify transcription factor binding sites
Reporter gene assays to quantify promoter activity
Genetic screens to identify regulatory factors
These approaches would help elucidate how S. agona coordinates SerC expression to balance its metabolic and cell division regulatory functions across different environmental conditions.
Genome structure analysis revealed multiple genomic arrangements, with rearranged isolates typically associated with early, convalescent carriage (3 weeks-3 months)
Increased SNP variation was observed during persistent infection periods
This genomic variation likely reflects selective pressures during infection that may affect metabolic genes including serC
These findings suggest that serC variants may contribute to adaptation during persistent infection, though direct sequencing studies focusing specifically on serC variation across S. agona isolates would be needed to confirm this hypothesis.
Advanced methods for S. agona detection include:
Bacteriophage-based reporter systems: Engineered bacteriophages expressing luciferase reporters have shown high sensitivity for Salmonella detection, with particular effectiveness for the Agona serovar. The TSP1.NL reporter phage produced substantially higher signals when detecting the Agona serovar compared to other detection methods .
PCR-based detection: Targeting serC and other conserved genes can provide specific identification.
Serological methods: Using antibodies against surface antigens specific to S. agona.
| Detection Method | Lower Limit of Detection | Time to Result | Specificity for S. agona |
|---|---|---|---|
| SEA1.NL Phage Reporter | ~1 CFU | 2 hours | High (99.3% of Salmonella strains) |
| TSP1.NL Phage Reporter | ~1 CFU | 2 hours | Medium (50.2% of strains, but strongest for Agona) |
| Combined Phage Cocktail | ~1 CFU | 2 hours | Very High |
The phage reporter systems have demonstrated remarkable sensitivity, capable of detecting a single CFU after only a 2-hour infection period, making them particularly valuable for research applications requiring rapid, sensitive detection .
Recombinant SerC offers several potential avenues for antimicrobial development:
Structure-based inhibitor design: Using the recombinant protein structure to design small molecule inhibitors that specifically target SerC
Vaccine development: Exploiting SerC as an antigen for developing vaccines against S. agona
Diagnostic applications: Using anti-SerC antibodies for rapid detection of S. agona in clinical or food samples
Combination therapies: Targeting SerC in conjunction with cell wall synthesis inhibitors to enhance bactericidal effects
The dual functionality of SerC makes it particularly attractive as an antimicrobial target, as inhibition could simultaneously disrupt both metabolism and cell division processes. Given the increasing prevalence of multidrug-resistant S. agona strains , novel targets like SerC are becoming increasingly important for future antimicrobial development.
Future research on SerC in S. agona should focus on:
Structural biology approaches: Determining the three-dimensional structure of S. agona SerC through X-ray crystallography or cryo-EM to understand the molecular basis of its dual functionality
Systems biology integration: Investigating how SerC functions within the broader metabolic and cell division networks using multi-omics approaches
Host-pathogen interaction studies: Examining how SerC activity changes during infection and how these changes contribute to persistence
Comparative analysis across serovars: Investigating whether differences in SerC function contribute to the varying virulence and persistence capabilities of different Salmonella serovars
Development of separation-of-function mutants: Creating and characterizing mutants that specifically lack either the biosynthetic or anti-septation activities to better understand each function independently
These research directions would significantly advance our understanding of this multifunctional enzyme and potentially lead to new strategies for controlling S. agona infections in both clinical and food safety contexts.